跳至主要内容
临床试验/NCT01098552
NCT01098552已完成不适用

Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 4,900 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
4,900
试验地点
1

研究概览

简要总结

This research study is being done to collect regular and routine follow-up information related to the outcome of treatment for prostate cancer.

This study is also being done to relate treatment outcome to measurement of substances in the blood such as prostate-specific antigen (PSA) and other markers. Also environmental and genetic factors that might be responsible for prostate cancer are being investigated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Informed consent explained and signed prior to any study related procedures.
  • Age ≥18 years
  • Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better, or Karnofsky performance of 60% or better.
  • Histologically confirmed adenocarcinoma of the prostate within 10 years of study entry.
  • Willingness to return to Mayo Clinic Rochester for follow-up or participate in mail-in PSA processing.
  • Must be disease-free from a previous diagnosis of cancer for a period of time = 5 years excluding cutaneous malignancies of squamous cell or basal cell carcinoma.

排除标准

  • Life expectancy < 5 years.
  • Inability to return to Mayo Rochester for follow-up appointments, sera, and urine collection per protocol.
  • Previous or a concurrent diagnosis of cancers other than basal cell or invasive squamous cell carcinoma of skin within the past 5 years.

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Karnes

Principal Manager

Mayo Clinic

研究点 (1)

Loading locations...

相似试验